ALLO - Allogene Therapeutics GAAP EPS of -$0.51 misses by $0.06
2024-03-14 16:24:11 ET
More on Allogene Therapeutics
- Allogene Therapeutics: A Promising Biotech With A Concerning Lag Time Ahead
- Allogene Therapeutics Q4 2023 Earnings Preview
- Allogene drops on layoffs and pipeline reorganization (update)
- Seeking Alpha’s Quant Rating on Allogene Therapeutics
- Historical earnings data for Allogene Therapeutics